Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study

Background. The ABO blood-type barrier in kidney and liver transplantation has been overcome by aggressive treatments such as B cell depletion using rituximab. However, the long-term effects of ABO-incompatible liver transplantation (ABO-I LTx) on immunological status have not previously been studie...

Full description

Bibliographic Details
Main Authors: Daisuke Ueda, MD, Atsushi Yoshizawa, MD, PhD, Masakatsu Kaneshiro, MD, Yoshihiro Hirata, MD, PhD, Shintaro Yagi, MD, PhD, Koichiro Hata, MD, PhD, Hideaki Okajima, MD, PhD, Hiroto Egawa, MD, PhD, Shinji Uemoto, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2019-01-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000858

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000858

Similar Items